The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

Finckh, Axel; Neto, D; Iannone, F; Loza, E; Lie, E; van Riel, P; Hetland, M L; Pavelka, K; Gottenberg, J E; Canhão, H; Mariette, X; Turesson, C

doi:10.1136/rmdopen-2014-000040

Scientific article

English

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

ContributorsFinckh, Axel

; Neto, D; Iannone, F; Loza, E; Lie, E; van Riel, P; Hetland, M L; Pavelka, K; Gottenberg, J E; Canhão, H; Mariette, X; Turesson, C

Published inRMD open, vol. 1, no. 1, e000040

Publication date2015

Abstract

There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) retention in patients with rheumatoid arthritis (RA) treated in clinical practice.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Inflammation articulaire (44)

Citation (ISO format)

FINCKH, Axel et al. The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries. In: RMD open, 2015, vol. 1, n° 1, p. e000040. doi: 10.1136/rmdopen-2014-000040

Article (Published version)

Identifiers

PID : unige:87993
DOI : 10.1136/rmdopen-2014-000040
PMID : 26509062

Journal ISSN2056-5933

485views

261downloads

Creation31/08/2016 10:52:00

First validation31/08/2016 10:52:00

Update24/01/2025 14:32:16

Status update24/01/2025 14:32:16

Last indexation24/01/2025 14:40:25

Archive ouverte UNIGE

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

Technical informations